FROM THE ALZHEIMER’S ASSOCIATION INTERNATIONAL CONFERENCE 2025: ALZHEIMER’S ASSOCIATION RELEASES ITS FIRST CLINICAL PRACTICE GUIDELINE FOR BLOOD-BASED BIOMARKER TESTS
Key Takeaways At AAIC 2025, the Alzheimer's Association released the first in…
Alamar Biosciences and the German Center for Neurodegenerative Diseases (DZNE) partner for Landmark Proteomic Profiling study in the Rhineland Study Cohort
NULISAseqâ„¢ CNS Disease Panel 120 and Inflammation Panel 250 to Power Biomarker…
imPAC Labs and Varonis Partner to Deliver Holistic Data & Cloud Security
July 29, 2025 11:00 ET Â | Source: imPAC Labs Atlanta, GA, July…
TUMI INTRODUCES NEW ASIA-PACIFIC BRAND AMBASSADOR WEI DAXUN
A new journey begins with Wei Daxun, as TUMI unveils the final…
Kyowa Kirin Announces Abstract Presentation at the European Academy of Dermatology and Venereology (EADV) Congress
PRINCETON, N.J. and TOKYO, July 29, 2025 /PRNewswire/ -- Kyowa Kirin Co.,…
The Saggi of Lamborghini Polo Storico
For the tenth anniversary of Polo Storico, testimonials from those who have…
Introducing DXC Assure Risk Management: AI-Powered Claims Solution for Self-Insured Organizations
ASHBURN, Va., July 29, 2025 /PRNewswire/ -- DXC Technology (NYSE: DXC), a…
Canara HSBC Life Insurance Launches SecureInvest- A Unit-linked Plan Offering Life Cover up to 100x of Annualised Premium
SecureInvest Rewards Long-Term Commitment with Loyalty Additions and Maturity BoostersTailored for Every…
FDA Approves Apellis EMPAVELI (pegcetacoplan) as the First C3G and Primary IC-MPGN Treatment for Patients 12 and Older
Proven efficacy across all three key markers of disease—68% reduction in proteinuria,…
ASM announces completion of share buyback program
Almere, The NetherlandsJuly 28, 2025, 5:45 p.m. CET ASM International N.V. (Euronext…